U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 292 records

Showing results for "opioids".
Users also searched for: opioid

  1. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug/alcohol abuse excluded Opioids … abdominal pain Excluded daily cannabis use in past 3 years Mean 53 50 96 2 NR 2 NR NR NR Excluded Weak opioids … : 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days 1 to 5: 3 mg 3 times/d; days 6 … psoriatic arthritis Previous CBD use: 18% Median 62 44 NR NR NR NR NR NR NR NR Concomitant medicine: Opioids … with severe psychiatric diseases (severe depression and schizophrenia) excluded Concomitant use of opioids

  2. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug/alcohol abuse excluded Opioids … abdominal pain Excluded daily cannabis use in past 3 years Mean 53 50 96 2 NR 2 NR NR NR Excluded Weak opioids … : 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days 1 to 5: 3 mg 3 times/d; days 6 … psoriatic arthritis Previous CBD use: 18% Median 62 44 NR NR NR NR NR NR NR NR Concomitant medicine: Opioids … with severe psychiatric diseases (severe depression and schizophrenia) excluded Concomitant use of opioids

  3. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug/alcohol abuse excluded Opioids … abdominal pain Excluded daily cannabis use in past 3 years Mean 53 50 96 2 NR 2 NR NR NR Excluded Weak opioids … : 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days 1 to 5: 3 mg 3 times/d; days 6 … psoriatic arthritis Previous CBD use: 18% Median 62 44 NR NR NR NR NR NR NR NR Concomitant medicine: Opioids … with severe psychiatric diseases (severe depression and schizophrenia) excluded Concomitant use of opioids

  4. Treatments for Acute Pain | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/treatments-acute-pain/research

  5. AHRQ’s Evidence-based Practice Center Program: Synthesizing evidence to improve health care practice and delivery (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
    November 01, 2022 - AHRQ’s Evidence-based Practice Center Program: Synthesizing evidence to improve health care practice and delivery What Is the Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center Program? AHRQ is the lead Federal Agency within the U.S. Department of Health and Human Services that is char…

  6. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahr…

  7. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - abdominal pain Excluded daily cannabis use in past 3 years Mean 53 50 96 2 NR 2 NR NR NR Excluded Weak opioids … : 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days 1 to 5: 3 mg 3 times/d; days 6 … with a personal or family history of schizophrenia or psychotic disorders excluded Previous treatment opioids … psoriatic arthritis Previous CBD use: 18% Median 62 44 NR NR NR NR NR NR NR NR Concomitant medicine: Opioids … with severe psychiatric diseases (severe depression and schizophrenia) excluded Concomitant use of opioids

  8. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - Studies comparing atypical opioids with placebo identified through ClinicalTrials.gov, published literature … For another two comparisons (lacosamide versus placebo and atypical opioids versus placebo), we found … No effect No effect Atypical opioids vs. … CT.gov = ClinicalTrials.gov; RCT = randomized controlled trial 34 Atypical Opioids Versus … Studies comparing atypical opioids with placebo identified through ClinicalTrials.gov, published literature

  9. A Rapid Evidence Review of Retention Strategies for Medications for Addiction Treatment (MAT) in Adults with Opioid Use Disorder | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol

  10. Executive Summary_Comparative Effectiveness Review No. 254: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
    December 01, 2022 - Executive Summary_Comparative Effectiveness Review No. 254: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication Comparative Effectiveness Review Number 254 Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication Executive Summary Main Points • Use …

  11. Alcohol-misuse-drug-therapy-140326 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
    January 27, 2012 - Opioid antagonist; competitively binds to opioid receptors and may block the effects of endogenous opioids

  12. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug/alcohol abuse excluded Opioids … abdominal pain Excluded daily cannabis use in past 3 years Mean 53 50 96 2 NR 2 NR NR NR Excluded Weak opioids … : 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days 1 to 5: 3 mg 3 times/d; days 6 … psoriatic arthritis Previous CBD use: 18% Median 62 44 NR NR NR NR NR NR NR NR Concomitant medicine: Opioids … with severe psychiatric diseases (severe depression and schizophrenia) excluded Concomitant use of opioids

  13. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - duration of insomnia: 143 vs. 141 vs. 136 months Mean duration of FM: 115 vs. 95 vs. 110 months % taking Opioids … Primary outcomes were yes/no use of sleep medication or opioids. 6 months Mean (SE) A vs. … medication (including NSAIDS, analgesics, selective serotonin releasing agents, anticonvulsants, and opioids

  14. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - duration of insomnia: 143 vs. 141 vs. 136 months Mean duration of FM: 115 vs. 95 vs. 110 months % taking Opioids … Primary outcomes were yes/no use of sleep medication or opioids. 6 months Mean (SE) A vs. … medication (including NSAIDS, analgesics, selective serotonin releasing agents, anticonvulsants, and opioids

  15. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
    February 01, 2013 - No eligible studies assessed opioids, sedative hypnotics, or tramadol, though these are used for RLS … No eligible studies assessed opioids, sedative hypnotics, or tramadol, though these are used clinically … What is the effectiveness of other drugs that are not dopamine agonists or alpha 2 ligands (e.g., opioids … What is the effectiveness of other drugs that are not dopamine agonists or alpha 2 ligands (e.g., opioids … What is the effectiveness of other drugs that are not dopamine agonists or alpha 2 ligands (e.g. opioids

  16. Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
    February 01, 2024 - clinics, acute care hospitals, long-term care Age ≥65 years and taking benzodiazepi nes and/or opioids … • decreased benzodiazepines and/or opioids, with variable effect for different interventions … Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review

  17. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
    August 24, 2011 - Alternatives/comparators to nitrous oxide include: epidural analgesia/anesthesia; systemic drugs such as opioids … include, but are not limited to, epidural analgesia, paracervical block, pudendal block, and parenteral opioids

  18. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug/alcohol abuse excluded Opioids … abdominal pain Excluded daily cannabis use in past 3 years Mean 53 50 96 2 NR 2 NR NR NR Excluded Weak opioids … : 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days 1 to 5: 3 mg 3 times/d; days 6 … psoriatic arthritis Previous CBD use: 18% Median 62 44 NR NR NR NR NR NR NR NR Concomitant medicine: Opioids … with severe psychiatric diseases (severe depression and schizophrenia) excluded Concomitant use of opioids

  19. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
    December 23, 2015 - Untitled Source: www.effectivehealthcare.ahrq.gov Published online: December 23, 2015 Evidence-based Practice Center Systematic Review Protocol Project Title: Suicide Prevention I. Background and Objectives for the Systematic Review Despite advances in the diagnosis and treatment of major mental disord…

  20. Optimizing Safety of Analgesic Use Among Patients with Arthritis | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/arthritis-analgesics-safety/research
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites